Clinical Trial Update: First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line FOLFIRI plus bevacizumab in colorectal cancer has completed; the update notes completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Camptosar (irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | Conditions: Colorectal Cancer Stage II | Phase 2 | Status: COMPLETED